1. 31. See (last visited August 16, 2012).
2. Update on JAMA 's Policies on Conflicts of Interest, Trial Registration, Embargo, and Data Timeliness, Access, and Analysis
3. 39. See Drazen, supra note 10.
4. “VNS Therapy in Treatment-Resistant Depression: Clinical Evidence and Putative Neurobiological Mechanisms,”;Jones;Neuropsychopharmacology,2006
5. 41. BMJ, “Editorial Staff,” available at (last visited July 25, 2012); PloS Medicine, “Competing Interests of the PLoS Medicine Editors,” available at (last visited July 25, 2012).